(PDF) MA19.04 the Clinical Implication of Frameshift Indel

MA19.04 the Clinical Implication of Frameshift Indel Mutation Burden in Non-Small Cell Lung Cancer (NSCLC)

Journal of Thoracic Oncology - United States

doi 10.1016/j.jtho.2018.08.476

Full Text

Abstract

Available in full text

Categories

Respiratory Medicine

Date

October 1, 2018

Authors

Publisher

Elsevier BV

Related search

P1.04-25 the Implication of Frameshift Mutation Burden in Neoantigen and Immune Cell Landscape in Non-Small Cell Lung Cancer (NSCLC)

Journal of Thoracic Oncology

Respiratory Medicine

English

Checkpoint Inhibitors in Squamous Non-Small Cell Lung Cancer (NSCLC)

Open Access Journal of Oncology and Medicine

English

MA16.06 EGFR Clonality and Tumor Mutation Burden (TMB) by Circulating Tumor DNA (ctDNA) Sequencing in Advanced Non-Small Cell Lung Cancer (NSCLC)

Journal of Thoracic Oncology

Respiratory Medicine

English

P1.09-36 Clinical Significance of Cannabinoid Receptor CB2 Expression in Non Small Cell Lung Cancer (NSCLC)

Journal of Thoracic Oncology

Respiratory Medicine

English

P107 the Study of Relationship Between Tumor Burden (TMB) and Molecular Typing of Non-Small Cell Lung Cancer (NSCLC)

Journal of Thoracic Oncology

Respiratory Medicine

English

MA06.07 Genetic and Epigenetic Alterations Are Associated With Tumor Mutation Burden in Non-Small Cell Lung Cancer

Journal of Thoracic Oncology

Respiratory Medicine

English

P3.15-29 Defining the Symptom Burden of Non-Small Cell Lung Cancer

Journal of Thoracic Oncology

Respiratory Medicine

English

PCN134 Patient Preferences for Non-Small Cell Lung Cancer (NSCLC) Treatments

Value in Health

Occupational Health

English

MicroRNA‐based Biomarkers for Diagnosis of Non‐small Cell Lung Cancer (NSCLC)

Thoracic Cancer

Respiratory Medicine

English